Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients

Transplantation

Volumn 67, Issue 1, 1999, Pages 94-97

  Humar, Abhinav ^a   Uknis, Marc ^a   Carlone Jambor, Cassandra ^a   Gruessner, Rainer W ^a   Dunn, David L ^a   Matas, Arthur ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR;

AGE; ARTICLE; CADAVER DONOR; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE COURSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; RISK FACTOR;

ANTIVIRAL AGENTS; CADAVER; CYTOMEGALOVIRUS INFECTIONS; DIABETES COMPLICATIONS; GANCICLOVIR; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MULTIVARIATE ANALYSIS; PANCREAS TRANSPLANTATION; RECURRENCE; RISK FACTORS; TISSUE DONORS;

EID: 0033556557     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00016     Document Type: Article

References (20)

1. Fryd DS, Peterson PK, Ferguson RM, et al. Cytomegalovirus as a risk factor in renal transplantation. Transplantation 1980; 30: 436.
2. Peterson PK, Balfour HH, Marker SC, et al. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 1980; 59: 283.
3. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive CMV disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51: 98.
4. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 1443.
5. Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995; 59: 1010.
6. Sawyer MD, Mayoral JL, Gillingham KJ, et al. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg 1993; 128: 165.
7. Hibberd PL, Basgoz N, Fishman J, et al. Primary cytomegalovirus (CMV) disease is a risk factor for recurrent CMV disease in transplant recipients [Abstract H28]. In: Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). American Society for Microbiology, 1994: 136.
8. Falgas ME, Snydman DR, Griffith J, et al. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Clin Infect Dis 1997; 25: 314.
9. Falgas ME, Snydman DR. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transplant Proc 1995; 27: 34.
10. Van den Berg AP, Van Son WJ, Haagsma EB, et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 1993; 55: 847.
11. Mayoral JL, Loeffler CM, Fasola CG, et al. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg 1991; 126: 202.
12. Gould FK, Freeman R, Taylor CE, et al. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant 1993; 12: 695.
13. Kirklin JK, Naftel DC, Levine TB, et al. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. J Heart Lung Transplant 1994; 13: 394.
14. Jordan ML, Hrebinko RL Jr, Dummer JS, et al. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol 1992; 148: 1388.
15. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD. Causes of renal allograft loss: progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214: 679.
16. Gruessner RWG, Sutherland DER. Pancreas transplantation. Part II. The recipient operation. Surg Rounds 1994; 17: 383.
17. Balfour HH, Chace BA, Stapleton JT. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989; 320: 1381.
18. Paya CV, Hermans PE, Smith TF, et al. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 1988; 46: 229.
19. Harbison MA, De Girolami PC, Jenkins RL, Hammer SM. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation 1988; 46: 82.
20. Dunn DL, Gillingham KJ, Kramer MA, et al. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation 1994; 57: 876.